Latest Derivatives News

Astron Limited has completed a Bankable Feasibility Study for Phase 1 of its Donald Rare Earth and Mineral Sands Project, confirming robust economics and advanced financing talks ahead of a targeted Q2 2026 Final Investment Decision.

Cynata Therapeutics has completed the 100-day primary evaluation period for its Phase 2 trial of CYP-001 in acute graft versus host disease, with results expected in June 2026. This milestone marks a critical step for the biotech’s lead cell therapy candidate in a condition with few effective treatments.

Kali Metals has secured 100% ownership of the DOM’s Hill Project in Western Australia, unveiling multiple shallow, high-grade gold targets from historical data. The company plans to accelerate exploration activities in 2026, leveraging recent funding and a large tenement package.

CAR Group Limited has announced the issue price for shares under its Dividend Reinvestment Plan (DRP) at $23.409 per share for the FY26 interim dividend, reflecting recent trading activity.

Westpac Banking Corporation has announced a fully franked distribution of AUD 1.3609 per Westpac Capital Note 7, reflecting a 5.3991% annualised rate for the quarter ending June 22, 2026.

Resolution Minerals has confirmed exceptional tungsten grades in stockpiles at its newly acquired Johnson Creek Mill, setting the stage for a rapid JORC upgrade and potential near-term production aligned with US critical minerals strategies.

GCM Corporation has completed the full transfer of its proprietary Very High Density (VHD) technology, gaining exclusive global ownership with payments tied to future revenue milestones.

Botala Energy’s latest well S3.3 results at the Serowe Coal Bed Methane Project reveal promising multi-seam gas potential and effective low-cost stimulation, boosting confidence in commercial viability.

Patagonia Lithium has reported lithium assay results up to 412ppm from its Formentera well, surpassing the project average and setting the stage for an updated Mineral Resource Estimate and further drilling.

Green360 Technologies has inked a binding toll treatment agreement with Calix Limited to commercially produce Eco-Clay, a low-carbon cement replacement, marking a key step toward scaling sustainable concrete solutions in Australia.

ABx Group’s mixed rare earth carbonate from Tasmania’s Deep Leads project has earned strong validation from US-based Rare Earth Technologies Inc, confirming its high purity and compatibility with cutting-edge separation technology.

AdAlta Limited has been granted a key Canadian patent for its anti-fibrotic drug AD-214, completing its composition of matter protection across all major commercial markets. This milestone strengthens the company’s intellectual property portfolio and underpins its commercial strategy for AD-214.